CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One of $20.52 million as of 2015-12-26, per its 10-K filed 2016-02-12.
Discontinued › Notes › Investments › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue · last filed 2016-02-12
- 2015-12-26: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $20.52M.
- 2014-12-27: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $16.17M.
- 2013-12-28: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $11.16M.
- 2013-09-28: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $11.08M.
| Period end | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One |
|---|---|
| 2015-12-26 | $20.52M 10-K · filed 2016-02-12 |
| 2014-12-27 | $16.17M 10-K · filed 2016-02-12 |
| 2013-12-28 | $11.16M 10-K · filed 2014-02-25 |
| 2013-09-28 | $11.08M 10-Q · filed 2013-10-30 |
| 2013-06-29 | $6.93M 10-Q · filed 2013-07-31 |
| 2013-03-30 | $6.85M 10-Q · filed 2013-05-08 |
| 2012-12-29 | $6.78M 10-K · filed 2014-02-25 |
| 2012-09-29 | $6.35M 10-Q · filed 2012-11-01 |
| 2012-06-30 | $6.62M 10-Q · filed 2012-08-07 |
| 2012-03-31 | $6.14M 10-Q · filed 2012-05-04 |
| 2011-12-31 | $5.36M 10-K · filed 2013-02-27 |
| 2011-09-24 | $6.19M 10-Q · filed 2011-11-02 |
| 2011-06-25 | $11.78M 10-Q · filed 2011-08-03 |
| 2010-12-25 | $9.83M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |